Order Revanesse® Pure™ w/ Lidocaine for Clinics

Revanesse® Pure™ w/ Lidocaine is a sterile hyaluronic acid injectable gel supplied in prefilled syringes for professional aesthetic use. Licensed clinics, med spas, and healthcare professionals can order this Revanesse Pure dermal filler for protocols that require smooth placement, documented lot tracking, and practical treatment-room handling. Each carton contains two 1.2 mL syringes with hyaluronic acid 25 mg/mL and lidocaine 0.3%.

The formulation is clear and colorless, with lidocaine included to support comfort during injection. It fits clinic workflows that use hyaluronic acid fillers for facial rejuvenation, contour refinement, soft-tissue support, and hydration-focused treatment planning under qualified professional judgment.

Revanesse Pure with Lidocaine Pack, Strength, and Ordering Details

Clinics ordering Revanesse Pure with Lidocaine should match the syringe count, concentration, and product role to the treatment plan documented by the injector. The supplied pack contains two single-use prefilled syringes, each containing 1.2 mL of gel. The formulation strength is hyaluronic acid 25 mg/mL with lidocaine 0.3%.

Sign in to view current Revanesse Pure price information, clinic purchasing details, and any volume structures available to your account. Account verification may apply for professional-use ordering, and labels support lot, expiration, and inventory documentation. Med Wholesale Supplies serves licensed clinics and healthcare professionals with brand-name medical products sourced through vetted distributors and verified supply channels.

Quick tip: Align reorder quantities with scheduled injection days, staff training sessions, and expected protocol use to avoid excess last-minute substitutions.

What the Injectable Gel Is Used For

Revanesse® Pure™ w/ Lidocaine is used by qualified injectors as a hyaluronic acid filler within aesthetic treatment plans. Clinics may use it when hydration, surface refinement, smoothing of visible folds, soft-tissue augmentation, or balanced contouring is appropriate. Final treatment area, injection depth, volume, and technique should be selected by trained professionals after clinical assessment.

Hyaluronic acid attracts and binds water in tissue, which helps create immediate, contourable volume after placement. The lidocaine component is an anesthetic included in the syringe to reduce discomfort during administration. Because the product is an injectable device used in delicate facial anatomy, staff should follow the manufacturer’s instructions for use, practice within their scope, and document the treatment plan clearly.

Clinics often evaluate this product as part of broader dermal filler purchasing. For teams building skin-quality protocols, the product may also sit alongside skin boosters when sequencing is clinically appropriate.

How It Works in Professional Aesthetic Workflows

The gel is designed for controlled extrusion through the injection tools selected by the practitioner. Smooth flow matters in treatment rooms because it supports steady placement, helps the injector maintain tactile feedback, and can reduce unnecessary setup changes during a session. The product’s in-tissue behavior should be assessed against the desired outcome, treatment plane, and patient-specific anatomy.

In practical terms, Revanesse Pure hyaluronic acid filler can support standardized workflows across injectors while still allowing technique preference. Teams may build protocols around facial mapping, conservative placement, staged refinement, and combination care with other aesthetic modalities. A structured approach helps new staff understand where a softer or more hydrating HA gel fits compared with firmer projection-focused fillers.

For education on feature-based planning within this product family, the article on Revanesse filler precision aesthetics can help teams discuss product-role differences without replacing formal training or manufacturer instructions.

Key Features for Clinic Purchasing

Clinic buyers usually assess fillers by concentration, syringe count, handling, documentation, and how well the product fits established protocols. Revanesse Pure injectable gel offers a practical format for teams that need a ready-to-use HA filler with an integrated anesthetic component.

• Hyaluronic acid concentration: 25 mg/mL.
• Lidocaine concentration: 0.3%.
• Two 1.2 mL prefilled syringes per carton.
• Clear, colorless sterile injectable gel.
• Single-use syringe format for professional administration.
• Sealed packaging designed to protect sterility before use.
• Labeling supports lot tracking, expiration records, and chart documentation.
• Fits aesthetic workflows that require controlled placement and predictable preparation.

Why it matters: A consistent syringe format helps purchasing teams standardize room setup, staff training, and inventory records across providers.

Composition and Ingredients

The active gel material is hyaluronic acid at 25 mg/mL. Hyaluronic acid is a naturally occurring glycosaminoglycan, a water-binding molecule found in the extracellular matrix. In an injectable filler, this material provides immediate placement-dependent volume and contouring under the control of the injector.

Lidocaine is included at 0.3% to support procedural comfort. The presence of lidocaine does not remove the need to screen for allergies, sensitivities, or treatment-specific risks. Clinics should review the instructions for use before administration and ensure staff understand contraindications, warnings, and appropriate adverse-event escalation.

Other excipients are included to maintain gel properties such as isotonicity and pH. Use the carton labeling and IFU as the controlling reference for the full ingredient list, handling instructions, and device-specific precautions.

Safety, Contraindications, and Tolerability

Injectable hyaluronic acid fillers can cause localized reactions after placement. Common short-term effects may include swelling, bruising, redness, tenderness, and discomfort at the injection site. These reactions are usually procedure-related, but clinics should give clear aftercare instructions and define when follow-up is needed.

Professional screening is essential before treatment. Practitioners should evaluate relevant medical history, allergies or sensitivities to lidocaine or filler components, active infection or inflammation at the treatment area, prior filler placement, medications that may increase bruising risk, and the patient’s goals. Administration into inappropriate tissue planes or vascular structures can cause serious complications, so injectors must use appropriate anatomy training and emergency protocols.

Clinics should document product name, lot number, expiration date, injection sites, technique, approximate volumes, device selection, and aftercare guidance. Adverse events should be assessed promptly by a qualified professional. When changing from another HA filler, the injector should account for gel behavior, prior treatment history, and the intended tissue effect rather than substituting only by syringe size.

Storage, Handling, and Treatment-Room Preparation

Keep sealed product in its original packaging until the treatment room is ready for use. Inspect the carton, blister, syringe, expiration date, and gel appearance before administration. Do not use a syringe if sterility appears compromised, packaging is damaged, labeling is unclear, or the gel appearance is inconsistent with the manufacturer’s instructions.

Single-use presentation supports clear room turnover and reduces ambiguity during documentation. Staff should prepare ancillary supplies before the appointment, including the appropriate needles or cannulas selected by the practitioner, antiseptic materials, gloves, sharps disposal, and emergency response materials required by clinic policy. For broader planning around filler selection and adjunct supplies, see the types of dermal fillers guide.

When required for a shipment, orders can be coordinated with temperature-controlled handling when required and tracked US delivery. Receiving staff should reconcile units against the purchase record, check expiration dates, and store cartons according to the product labeling and clinic procedure.

Professional Applications and Protocol Fit

Revanesse® Pure™ w/ Lidocaine may be used as a versatile HA gel in facial balancing and soft-tissue refinement protocols. It can support hydration-led aesthetic planning, fine-line softening, surface improvement, and gentle contour work when those goals match the clinical assessment. The product should not be positioned as a substitute for training, anatomical judgment, or individualized treatment planning.

Many clinics separate HA products by desired tissue behavior. Softer products may be used for smoother integration and refinement, while firmer products may be selected for structure or projection. That distinction helps staff communicate internally about product choice without implying that one filler is universally better than another.

For teams answering common patient questions about filler choice, the article Revanesse vs Juvederm discusses selection factors across brands. A separate article on lidocaine in dermal filler procedures can support staff discussions about comfort considerations.

Revanesse, Juvederm, Restylane, and Similar Fillers

Revanesse is not simply better or worse than Juvederm or Restylane. These brands include different HA technologies, product consistencies, indications, syringe formats, and handling profiles. A clinic’s best choice depends on treatment area, tissue quality, injector preference, desired lift or softness, prior treatment history, and the available product portfolio.

Use Revanesse® Pure™ w/ Lidocaine when its HA concentration, lidocaine content, syringe size, and expected gel behavior match the planned protocol. Consider alternative products when a firmer gel, different projection profile, or more localized shaping product is needed. Clinics should standardize internal guidance so staff do not select products based only on brand familiarity or patient request.

For a broad view of commonly used filler categories and facial areas, the article popular dermal fillers for the face can help frame training conversations. It should be used as general education, not as a treatment directive for a specific patient.

Comparable Revanesse Products

Clinics that stock Revanesse® Pure™ w/ Lidocaine often evaluate adjacent products in the same brand family. Keeping related formulations available can help injectors match gel behavior to the treatment objective instead of forcing one product into every indication.

• Revanesse Ultra Lido may be considered when firmer support is preferred by the practitioner.
• Revanesse Kiss Lido can fit localized shaping protocols when appropriate.
• Revanesse Revise w/ Lidocaine may complement refinement or skin-quality planning.

Brand-level browsing is available through the Revanesse portfolio. Product choice should remain tied to injector training, intended tissue effect, IFU guidance, and clinic policy.

Pricing, Inventory Planning, and Reorders

Revanesse Pure cost can vary by account terms, pack quantities, and current purchasing structures. Sign in to view live clinic pricing and coordinate quantities for your location. Multi-provider practices may prefer to forecast use by injector, procedure category, and average syringe consumption per appointment type.

Inventory planning should account for expiration dating, treatment-room turnover, seasonal demand, training sessions, and substitution rules. If a preferred SKU is temporarily constrained, practitioners should approve any class-equivalent replacement before staff schedule treatment around it. Gel characteristics, lidocaine presence, syringe volume, and procedural role all matter when substituting one filler for another.

For documentation, maintain purchase records, receiving checks, lot logs, and treatment notes in a consistent system. This supports traceability across providers and helps clinic managers reconcile used syringes, remaining stock, and upcoming replenishment needs.

Authoritative Sources

Use the manufacturer’s current instructions for use and product labeling as the primary source for administration, storage, contraindications, and warnings. Regulatory and professional guidance on dermal fillers can also help clinics maintain safe injectable protocols. Broken or outdated external references should not be used for clinical decision-making.

Because official web addresses can change, verify external manufacturer and regulator documents directly before relying on them for staff training or patient consent materials. Internal education can support product comparison, but the IFU and applicable professional standards remain the controlling references for treatment-room use.

Summary for Clinic Ordering

Revanesse® Pure™ w/ Lidocaine is a professional HA injectable gel supplied as two 1.2 mL prefilled syringes per carton. Its 25 mg/mL hyaluronic acid concentration and 0.3% lidocaine content make it a practical option for aesthetic clinics that need controlled placement, comfort support, and clear documentation.

Order quantities should reflect injector protocols, treatment volume, staff training, and expiration management. Sign in to view current clinic pricing, coordinate replenishment, and maintain continuity across scheduled aesthetic services.

This content is for informational purposes only and is not a substitute for professional medical advice.